Zhejiang Qianjiang Biochemical Co., Ltd (SHA:600796)
China · Delayed Price · Currency is CNY 4.750
+0.070 (1.50%)
Jul 27, 2026, 3:00 PM CST
SHA:600796 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 854.76 | 974.49 | 948.5 | 876.28 | 873.21 | 918.79 |
Cash & Short-Term Investments | 854.76 | 974.49 | 948.5 | 876.28 | 873.21 | 918.79 |
Cash Growth | 4.13% | 2.74% | 8.24% | 0.35% | -4.96% | 72.87% |
Accounts Receivable | 1,009 | 1,025 | 1,155 | 1,148 | 939.8 | 901.39 |
Other Receivables | 68.94 | 44.39 | 21.9 | 38.57 | 44.33 | 27.61 |
Receivables | 1,078 | 1,069 | 1,177 | 1,187 | 984.13 | 929 |
Inventory | 167.67 | 132.62 | 193.14 | 195.91 | 129.63 | 111.7 |
Prepaid Expenses | - | 9.85 | 12.78 | 11.58 | 7.51 | 11.31 |
Other Current Assets | 73.4 | 61.57 | 54.92 | 62.4 | 75.72 | 93.27 |
Total Current Assets | 2,174 | 2,248 | 2,386 | 2,333 | 2,070 | 2,064 |
Property, Plant & Equipment | 1,114 | 1,165 | 1,398 | 1,254 | 1,307 | 1,138 |
Long-Term Investments | 604.32 | 604.6 | 597.38 | 524.26 | 552.02 | 563.55 |
Other Intangible Assets | 3,362 | 3,377 | 3,050 | 2,640 | 2,669 | 2,625 |
Long-Term Deferred Tax Assets | 59.88 | 59.26 | 42.44 | 41.09 | 37.3 | 38.98 |
Long-Term Deferred Charges | 17.11 | 18.67 | 21.24 | 15.35 | 14.62 | 10.71 |
Other Long-Term Assets | 123.53 | 122.68 | 56.08 | 63.49 | 47.22 | 50.06 |
Total Assets | 7,455 | 7,594 | 7,551 | 6,871 | 6,697 | 6,490 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 777.96 | 655.89 | 606.99 | 571.77 | 409.17 | 470.39 |
Accrued Expenses | 31.59 | 60.64 | 74.72 | 83.39 | 72.55 | 76.54 |
Short-Term Debt | 348.55 | 332.65 | 488.7 | 592.57 | 366.66 | 646.68 |
Current Portion of Long-Term Debt | 209.43 | 212.91 | 247.59 | 399.57 | 277.04 | 236.25 |
Current Portion of Leases | - | 0.67 | 0.89 | 0.16 | 0.3 | 0.16 |
Current Income Taxes Payable | 37.28 | 19.11 | 8.34 | 9.23 | 13.48 | 18.12 |
Current Unearned Revenue | 77.83 | 67.48 | 17.86 | 24.74 | 27.56 | 34.07 |
Other Current Liabilities | 8.42 | 377.05 | 197.02 | 265.53 | 315.47 | 160.02 |
Total Current Liabilities | 1,491 | 1,726 | 1,642 | 1,947 | 1,482 | 1,642 |
Long-Term Debt | 1,400 | 1,402 | 1,739 | 974.5 | 1,363 | 1,292 |
Long-Term Leases | 1.59 | 0.68 | 1.58 | 0.08 | 0.24 | 0.08 |
Long-Term Unearned Revenue | 310.62 | 308.16 | 224.14 | 120.98 | 121.41 | 130.78 |
Long-Term Deferred Tax Liabilities | - | - | 0.88 | 0.45 | 0.48 | 0.51 |
Other Long-Term Liabilities | 506.65 | 451.96 | 386.49 | 331.62 | 327.37 | 120.5 |
Total Liabilities | 3,710 | 3,889 | 3,994 | 3,375 | 3,295 | 3,186 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 866.59 | 866.59 | 866.59 | 866.59 | 866.59 | 866.59 |
Additional Paid-In Capital | 1,464 | 1,464 | 1,463 | 1,463 | 1,463 | 1,463 |
Retained Earnings | 1,128 | 1,091 | 928.81 | 795.67 | 673.38 | 553.99 |
Comprehensive Income & Other | 18.19 | 18.35 | 17.29 | 12.81 | 11.96 | 9.75 |
Total Common Equity | 3,476 | 3,440 | 3,276 | 3,138 | 3,015 | 2,893 |
Minority Interest | 268.73 | 265.07 | 280.61 | 358.6 | 387.49 | 411.09 |
Shareholders' Equity | 3,745 | 3,705 | 3,557 | 3,497 | 3,402 | 3,304 |
Total Liabilities & Equity | 7,455 | 7,594 | 7,551 | 6,871 | 6,697 | 6,490 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,959 | 1,949 | 2,478 | 1,967 | 2,007 | 2,175 |
Net Cash (Debt) | -1,105 | -974.29 | -1,529 | -1,091 | -1,134 | -1,256 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.21 | -1.11 | -1.72 | -1.24 | -1.32 | -1.87 |
Filing Date Shares Outstanding | 866.59 | 866.59 | 866.59 | 866.59 | 866.59 | 866.59 |
Total Common Shares Outstanding | 866.59 | 866.59 | 866.59 | 866.59 | 866.59 | 866.59 |
Working Capital | 682.6 | 521.18 | 743.77 | 385.76 | 587.99 | 421.85 |
Book Value Per Share | 4.01 | 3.97 | 3.78 | 3.62 | 3.48 | 3.34 |
Tangible Book Value | 114.17 | 63.29 | 225.8 | 498.18 | 345.66 | 268.46 |
Tangible Book Value Per Share | 0.13 | 0.07 | 0.26 | 0.57 | 0.40 | 0.31 |
Buildings | - | 674.15 | 640.86 | 599.12 | 580 | 556.83 |
Machinery | - | 595.28 | 904.74 | 942.78 | 903.54 | 897.63 |
Construction In Progress | - | 405.81 | 431.04 | 206.4 | 298.61 | 84.39 |